Danxia Gu
- Molecular Medicine top 0.02%
- Antibiotic Resistance in Bacteria 21
- Endocrinology top 0.1%
- Escherichia coli research studies 4
- Enterobacteriaceae and Cronobacter Research 3
- Infections and bacterial resistance 3
- Pollution top 0.5%
- Pharmaceutical and Antibiotic Environmental Impacts 5
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 6
-
- Bacterial biofilms and quorum sensing 5
-
- Antibiotics Pharmacokinetics and Efficacy 4
- Journals
- Frontiers in Microbiology (4 papers)Antimicrobial Agents and Chemotherapy (4 papers)The Lancet Infectious Diseases (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Danxia Gu
24 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Molecular Medicine 4.4k
- Endocrinology 1.5k
- Applied Microbiology and Biotechnology 458
- Pollution 1.7k
- Clinical Biochemistry 535
Countries citing papers authored by Danxia Gu
This map shows the geographic impact of Danxia Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danxia Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danxia Gu more than expected).
Fields of papers citing papers by Danxia Gu
This network shows the impact of papers produced by Danxia Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danxia Gu. The network helps show where Danxia Gu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Danxia Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 9 | |
| 5 | 2023 | 13 | |
| 6 | 2022 | 29 | |
| 7 | 2022 | 13 | |
| 8 | 2021 | 72 | |
| 9 | 2019 | 1 | |
| 10 | 2019 | 31 | |
| 11 | 2019 | 27 | |
| 12 | 2018 | 14 | |
| 13 | A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological studybreakdown → | 2017 | 746 |
| 14 | 2016 | 28 | |
| 15 | 2015 | 78 | |
| 16 | Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological studybreakdown → | 2015 | 3933 |
| 17 | 2015 | 7 | |
| 18 | 2015 | 19 | |
| 19 | 2014 | 14 | |
| 20 | 2013 | 26 |
About Danxia Gu
Danxia Gu is a scholar working on Molecular Medicine, Endocrinology, Applied Microbiology and Biotechnology, Clinical Biochemistry and Pollution, having authored 25 papers that have together received 5.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (21 papers), Bacterial Identification and Susceptibility Testing (6 papers), Pharmaceutical and Antibiotic Environmental Impacts (5 papers), Bacterial biofilms and quorum sensing (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Escherichia coli research studies (4 papers), Enterobacteriaceae and Cronobacter Research (3 papers) and Infections and bacterial resistance (3 papers). The work is most often cited by research in Molecular Medicine (4.4k citations), Endocrinology (1.5k citations), Applied Microbiology and Biotechnology (458 citations), Pollution (1.7k citations) and Clinical Biochemistry (535 citations). Danxia Gu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Rong Zhang, Hongwei Zhou, Jianzhong Shen, Yang Wang, Hongwei Ren, Liang ZiSen, Yohei Doi, Guo‐Bao Tian, Baolei Dong and Xiaojie Chen. Their work appears in journals such as Frontiers in Microbiology, Antimicrobial Agents and Chemotherapy, The Lancet Infectious Diseases, Scientific Reports and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.